Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manipal Health EnterprisesNSE:MANIPALHOS -3.30%13 EBITDA Margin % is 25.92% as of Mar. 2026, which is at its 10-year median of 25.92. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 671 Healthcare Providers & Services companies, Manipal Health Enterprises ranks better than 86.29% on this metric.
Manipal Health Enterprises (NSE:MANIPALHOS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Manipal Health Enterprises EBITDA Margin % Related Terms
Manipal Health Enterprises EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises EBITDA Margin % Chart
Manipal Health Enterprises Annual Data
Trend
Mar24
Mar25
Mar26
EBITDA Margin %
25.44
26.50
25.92
Manipal Health Enterprises Semi-Annual Data
Mar24
Mar25
Mar26
EBITDA Margin %
25.44
26.50
25.92
NSE:MANIPALHOS vs : EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Manipal Health Enterprises's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manipal Health Enterprises EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Manipal Health Enterprises's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises (NSE:MANIPALHOS) has a EBITDA Margin % of 25.92% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Manipal Health Enterprises and its competitors. This is near median its historical median of 25.92. Over the past decade, Manipal Health Enterprises' EBITDA Margin % has ranged from 25.44 to 26.50. According to the industry distribution chart, Manipal Health Enterprises ranks #92 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 13.7%.
Is Manipal Health Enterprises' EBITDA Margin % too high?
Manipal Health Enterprises' current EBITDA Margin % of 25.92% is near median its 10-year median of 25.92. Over the past 10 years, this metric has ranged from a low of 25.44 to a high of 26.50. The Healthcare Providers & Services industry median EBITDA Margin % is 10.09. Manipal Health Enterprises' value of 25.92% is 156.9% above this industry median. Based on the distribution chart, Manipal Health Enterprises ranks #92 out of 671 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' EBITDA Margin % compare to ?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #92 out of 671 companies for EBITDA Margin %. This places Manipal Health Enterprises in the top 14% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.09. Manipal Health Enterprises' value of 25.92% is 156.9% above this benchmark. Historically, Manipal Health Enterprises' own EBITDA Margin % has ranged from 25.44 to 26.50 over the past decade. While the company's 10-year median is 25.92 vs. the industry median of 10.09, Manipal Health Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.09, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Manipal Health Enterprises's current EBITDA Margin % of 25.92% is 156.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Manipal Health Enterprises and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current EBITDA Margin % is 25.92%, which is near median its own 10-year median of 25.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current EBITDA Margin % of 25.92%. The current EBITDA Margin % is 25.92%, which is near median its 10-year median of 25.92 and 156.9% above the Healthcare Providers & Services industry median of 10.09. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current EBITDA Margin % is 25.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
